# FDA recall D-0209-2026

> **Blossom Pharmaceuticals** · Class II · drug recall initiated 2025-10-31.

## Product

Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.

## Reason for recall

cGMP deviations

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0209-2026
- **Recalling firm:** Blossom Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-10-31
- **Report date:** 2025-12-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bardej, Goa, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0209-2026

## Citation

> AI Analytics. FDA recall D-0209-2026. Retrieved 2026-07-11 from https://api.ai-analytics.org/recall/D-0209-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*